SecBot SecBot
SECBOTREPLAY Home › Report › CABA

CABA · T. Rowe Price 8.0% stake

Cabaletta Bio, Inc. · SC 13G/A filed Nov 6, 2026 at 10:58 ET

At the news

NEUTRALIMPACT 2/10

SC 13G/A filed Nov 6, 2026 at 10:58 ET

T. Rowe Price Investment Management filed an amended Schedule 13G for Cabaletta Bio, reporting beneficial ownership of 17,250,098 shares (8.0% of common stock) as of September 30, 2026. This is a routine passive stake update by a large asset manager; no prior T. Rowe Price 13G for CABA is in the provided context for comparison, so the direction of change is unknown. The filing has no material directional impact.

  • T. Rowe Price Investment Management reported beneficial ownership of 17,250,098 shares of Cabaletta Bio common stock as of September 30, 2026
  • The stake represents 8.0% of the outstanding common stock
  • The filing is an amendment to Schedule 13G, indicating passive investment intent
  • No prior T. Rowe Price 13G for CABA is in the provided context, so the direction of change from the previous filing is unknown

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access